Want to create an interactive transcript for this episode?
Podcast: Morgans Financial Limited (Imports from Soundcloud)
Episode: ResMed (ASX:RMD) Result Analyst Comments: Reporting Season, August 2023
Description: Morgans Senior Analyst Dr Derek Jellinek gives an update on ResMed's mixed 4Q, as strong sales across all product lines failed to translate into operating leverage. Check out more from Morgans: Visit the Morgans website: www.morgans.com.au Check out our blog: www.morgans.com.au/Blog On Facebook: www.facebook.com/MorgansAU On Instagram: www.instagram.com/Morgans.Australia On Twitter: twitter.com/MorgansAU